Alteplase

Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

To Compare the Efficacy & Safety of Ultra-Slow (24 hr) Low Dose (25 mg) Infusion of Alteplase Over Slow (24hr) Infusion of Streptokinase in Mechanical Prosthetic Valve Thrombosis

Reperfusion Treatment in Acute Pulmonary Embolism

Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）

Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction

Pulmonary Embolism International THrOmbolysis Study-3

Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE

Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS

24 Hours Treatment with Alteplase in Patients with Ischemic Stroke

The Norwegian Tenecteplase Stroke Trial 2

A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity

the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients

A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke

Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy

Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality

Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol